Equifax (EFX) Competitors

Equifax logo
$180.33 -9.17 (-4.84%)
Closing price 11/17/2026 03:59 PM Eastern
Extended Trading
$182.53 +2.20 (+1.22%)
As of 08:00 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

EFX vs. CRAI, APTV, BAH, G, and IQV

Should you buy Equifax stock or one of its competitors? Equifax's main competitors and comparable companies include Charles River Associates (CRAI), Aptiv (APTV), Booz Allen Hamilton (BAH), Genpact (G), and IQVIA (IQV). Companies are selected based on similarities in market, industry, and size.

How does Equifax compare to Charles River Associates?

Equifax (NYSE:EFX) and Charles River Associates (NASDAQ:CRAI) are both industrials companies, but which is the better stock? We will contrast the two companies based on the strength of their valuation, dividends, risk, institutional ownership, earnings, media sentiment, analyst recommendations and profitability.

In the previous week, Equifax had 14 more articles in the media than Charles River Associates. MarketBeat recorded 15 mentions for Equifax and 1 mentions for Charles River Associates. Charles River Associates' average media sentiment score of 1.25 beat Equifax's score of 0.87 indicating that Charles River Associates is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Equifax
5 Very Positive mention(s)
1 Positive mention(s)
4 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Positive
Charles River Associates
0 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Equifax has higher revenue and earnings than Charles River Associates. Charles River Associates is trading at a lower price-to-earnings ratio than Equifax, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Equifax$6.07B3.47$660.30M$6.1929.13
Charles River Associates$751.58M1.75$54.78M$7.9826.27

Equifax has a beta of 1.27, suggesting that its share price is 27% more volatile than the broader market. Comparatively, Charles River Associates has a beta of 0.64, suggesting that its share price is 36% less volatile than the broader market.

Equifax pays an annual dividend of $2.24 per share and has a dividend yield of 1.2%. Charles River Associates pays an annual dividend of $2.28 per share and has a dividend yield of 1.1%. Equifax pays out 36.2% of its earnings in the form of a dividend. Charles River Associates pays out 28.6% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. Equifax has raised its dividend for 1 consecutive years and Charles River Associates has raised its dividend for 7 consecutive years.

96.2% of Equifax shares are owned by institutional investors. Comparatively, 84.1% of Charles River Associates shares are owned by institutional investors. 1.7% of Equifax shares are owned by insiders. Comparatively, 4.5% of Charles River Associates shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.

Equifax has a net margin of 11.27% compared to Charles River Associates' net margin of 6.28%. Charles River Associates' return on equity of 27.73% beat Equifax's return on equity.

Company Net Margins Return on Equity Return on Assets
Equifax11.27% 22.48% 8.52%
Charles River Associates 6.28%27.73%8.23%

Equifax currently has a consensus price target of $196.71, suggesting a potential upside of 9.08%. Charles River Associates has a consensus price target of $245.00, suggesting a potential upside of 16.86%. Given Charles River Associates' higher probable upside, analysts plainly believe Charles River Associates is more favorable than Equifax.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Equifax
0 Sell rating(s)
8 Hold rating(s)
14 Buy rating(s)
0 Strong Buy rating(s)
2.64
Charles River Associates
0 Sell rating(s)
1 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
2.50

Summary

Equifax beats Charles River Associates on 12 of the 19 factors compared between the two stocks.

How does Equifax compare to Aptiv?

Aptiv (NYSE:APTV) and Equifax (NYSE:EFX) are related companies, but which is the superior business? We will contrast the two businesses based on the strength of their institutional ownership, media sentiment, risk, profitability, analyst recommendations, valuation, earnings and dividends.

Equifax has a net margin of 11.27% compared to Aptiv's net margin of 4.60%. Equifax's return on equity of 22.48% beat Aptiv's return on equity.

Company Net Margins Return on Equity Return on Assets
Aptiv4.60% 15.44% 6.63%
Equifax 11.27%22.48%8.52%

Aptiv presently has a consensus target price of $67.75, indicating a potential upside of 79.10%. Equifax has a consensus target price of $196.71, indicating a potential upside of 9.08%. Given Aptiv's stronger consensus rating and higher probable upside, research analysts plainly believe Aptiv is more favorable than Equifax.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Aptiv
1 Sell rating(s)
7 Hold rating(s)
16 Buy rating(s)
1 Strong Buy rating(s)
2.68
Equifax
0 Sell rating(s)
8 Hold rating(s)
14 Buy rating(s)
0 Strong Buy rating(s)
2.64

In the previous week, Equifax had 10 more articles in the media than Aptiv. MarketBeat recorded 15 mentions for Equifax and 5 mentions for Aptiv. Equifax's average media sentiment score of 0.87 beat Aptiv's score of -0.07 indicating that Equifax is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Aptiv
1 Very Positive mention(s)
2 Positive mention(s)
0 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Neutral
Equifax
5 Very Positive mention(s)
1 Positive mention(s)
4 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Positive

Aptiv has a beta of 1.43, indicating that its stock price is 43% more volatile than the broader market. Comparatively, Equifax has a beta of 1.27, indicating that its stock price is 27% more volatile than the broader market.

94.2% of Aptiv shares are owned by institutional investors. Comparatively, 96.2% of Equifax shares are owned by institutional investors. 0.1% of Aptiv shares are owned by insiders. Comparatively, 1.7% of Equifax shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.

Equifax has lower revenue, but higher earnings than Aptiv. Aptiv is trading at a lower price-to-earnings ratio than Equifax, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Aptiv$20.40B0.38$165M$3.6310.42
Equifax$6.07B3.47$660.30M$6.1929.13

Summary

Equifax beats Aptiv on 11 of the 17 factors compared between the two stocks.

How does Equifax compare to Booz Allen Hamilton?

Equifax (NYSE:EFX) and Booz Allen Hamilton (NYSE:BAH) are both large-cap industrials companies, but which is the better investment? We will compare the two companies based on the strength of their institutional ownership, earnings, analyst recommendations, dividends, profitability, media sentiment, risk and valuation.

96.2% of Equifax shares are held by institutional investors. Comparatively, 91.8% of Booz Allen Hamilton shares are held by institutional investors. 1.7% of Equifax shares are held by company insiders. Comparatively, 1.1% of Booz Allen Hamilton shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.

Booz Allen Hamilton has higher revenue and earnings than Equifax. Booz Allen Hamilton is trading at a lower price-to-earnings ratio than Equifax, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Equifax$6.07B3.47$660.30M$6.1929.13
Booz Allen Hamilton$11.22B0.91$851M$6.4413.33

Equifax presently has a consensus price target of $196.71, indicating a potential upside of 9.08%. Booz Allen Hamilton has a consensus price target of $89.71, indicating a potential upside of 4.52%. Given Equifax's stronger consensus rating and higher possible upside, analysts clearly believe Equifax is more favorable than Booz Allen Hamilton.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Equifax
0 Sell rating(s)
8 Hold rating(s)
14 Buy rating(s)
0 Strong Buy rating(s)
2.64
Booz Allen Hamilton
3 Sell rating(s)
7 Hold rating(s)
5 Buy rating(s)
0 Strong Buy rating(s)
2.13

Equifax has a net margin of 11.27% compared to Booz Allen Hamilton's net margin of 7.14%. Booz Allen Hamilton's return on equity of 75.00% beat Equifax's return on equity.

Company Net Margins Return on Equity Return on Assets
Equifax11.27% 22.48% 8.52%
Booz Allen Hamilton 7.14%75.00%11.41%

In the previous week, Booz Allen Hamilton had 1 more articles in the media than Equifax. MarketBeat recorded 16 mentions for Booz Allen Hamilton and 15 mentions for Equifax. Equifax's average media sentiment score of 0.87 beat Booz Allen Hamilton's score of 0.83 indicating that Equifax is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Equifax
5 Very Positive mention(s)
1 Positive mention(s)
4 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Positive
Booz Allen Hamilton
2 Very Positive mention(s)
0 Positive mention(s)
3 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Equifax pays an annual dividend of $2.24 per share and has a dividend yield of 1.2%. Booz Allen Hamilton pays an annual dividend of $2.36 per share and has a dividend yield of 2.7%. Equifax pays out 36.2% of its earnings in the form of a dividend. Booz Allen Hamilton pays out 36.6% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. Equifax has raised its dividend for 1 consecutive years and Booz Allen Hamilton has raised its dividend for 14 consecutive years. Booz Allen Hamilton is clearly the better dividend stock, given its higher yield and longer track record of dividend growth.

Equifax has a beta of 1.27, suggesting that its share price is 27% more volatile than the broader market. Comparatively, Booz Allen Hamilton has a beta of 0.28, suggesting that its share price is 72% less volatile than the broader market.

Summary

Equifax beats Booz Allen Hamilton on 11 of the 19 factors compared between the two stocks.

How does Equifax compare to Genpact?

Equifax (NYSE:EFX) and Genpact (NYSE:G) are both industrials companies, but which is the superior business? We will contrast the two businesses based on the strength of their profitability, analyst recommendations, institutional ownership, dividends, risk, earnings, media sentiment and valuation.

Equifax pays an annual dividend of $2.24 per share and has a dividend yield of 1.2%. Genpact pays an annual dividend of $0.75 per share and has a dividend yield of 1.8%. Equifax pays out 36.2% of its earnings in the form of a dividend. Genpact pays out 21.9% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. Equifax has increased its dividend for 1 consecutive years and Genpact has increased its dividend for 6 consecutive years. Genpact is clearly the better dividend stock, given its higher yield and longer track record of dividend growth.

Equifax presently has a consensus target price of $196.71, indicating a potential upside of 9.08%. Genpact has a consensus target price of $41.89, indicating a potential downside of 1.91%. Given Equifax's stronger consensus rating and higher possible upside, analysts clearly believe Equifax is more favorable than Genpact.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Equifax
0 Sell rating(s)
8 Hold rating(s)
14 Buy rating(s)
0 Strong Buy rating(s)
2.64
Genpact
0 Sell rating(s)
7 Hold rating(s)
2 Buy rating(s)
0 Strong Buy rating(s)
2.22

96.2% of Equifax shares are held by institutional investors. Comparatively, 96.0% of Genpact shares are held by institutional investors. 1.7% of Equifax shares are held by company insiders. Comparatively, 1.6% of Genpact shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.

Equifax has a net margin of 11.27% compared to Genpact's net margin of 11.04%. Genpact's return on equity of 23.02% beat Equifax's return on equity.

Company Net Margins Return on Equity Return on Assets
Equifax11.27% 22.48% 8.52%
Genpact 11.04%23.02%10.57%

Equifax has a beta of 1.27, suggesting that its stock price is 27% more volatile than the broader market. Comparatively, Genpact has a beta of 0.53, suggesting that its stock price is 47% less volatile than the broader market.

In the previous week, Equifax had 4 more articles in the media than Genpact. MarketBeat recorded 15 mentions for Equifax and 11 mentions for Genpact. Equifax's average media sentiment score of 0.87 beat Genpact's score of 0.21 indicating that Equifax is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Equifax
5 Very Positive mention(s)
1 Positive mention(s)
4 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Positive
Genpact
3 Very Positive mention(s)
2 Positive mention(s)
4 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Neutral

Equifax has higher revenue and earnings than Genpact. Genpact is trading at a lower price-to-earnings ratio than Equifax, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Equifax$6.07B3.47$660.30M$6.1929.13
Genpact$5.08B1.41$552.49M$3.4312.45

Summary

Equifax beats Genpact on 14 of the 19 factors compared between the two stocks.

How does Equifax compare to IQVIA?

Equifax (NYSE:EFX) and IQVIA (NYSE:IQV) are related large-cap companies, but which is the better stock? We will contrast the two companies based on the strength of their analyst recommendations, valuation, institutional ownership, risk, media sentiment, earnings, dividends and profitability.

96.2% of Equifax shares are held by institutional investors. Comparatively, 89.6% of IQVIA shares are held by institutional investors. 1.7% of Equifax shares are held by insiders. Comparatively, 1.7% of IQVIA shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.

Equifax has a beta of 1.27, indicating that its share price is 27% more volatile than the broader market. Comparatively, IQVIA has a beta of 1.16, indicating that its share price is 16% more volatile than the broader market.

Equifax currently has a consensus price target of $196.71, indicating a potential upside of 9.08%. IQVIA has a consensus price target of $294.21, indicating a potential upside of 14.28%. Given IQVIA's stronger consensus rating and higher probable upside, analysts plainly believe IQVIA is more favorable than Equifax.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Equifax
0 Sell rating(s)
8 Hold rating(s)
14 Buy rating(s)
0 Strong Buy rating(s)
2.64
IQVIA
1 Sell rating(s)
2 Hold rating(s)
16 Buy rating(s)
2 Strong Buy rating(s)
2.90

Equifax has a net margin of 11.27% compared to IQVIA's net margin of 8.05%. IQVIA's return on equity of 30.02% beat Equifax's return on equity.

Company Net Margins Return on Equity Return on Assets
Equifax11.27% 22.48% 8.52%
IQVIA 8.05%30.02%6.52%

In the previous week, Equifax had 7 more articles in the media than IQVIA. MarketBeat recorded 15 mentions for Equifax and 8 mentions for IQVIA. Equifax's average media sentiment score of 0.87 beat IQVIA's score of 0.65 indicating that Equifax is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Equifax
5 Very Positive mention(s)
1 Positive mention(s)
4 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Positive
IQVIA
4 Very Positive mention(s)
1 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

IQVIA has higher revenue and earnings than Equifax. Equifax is trading at a lower price-to-earnings ratio than IQVIA, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Equifax$6.07B3.47$660.30M$6.1929.13
IQVIA$16.31B2.60$1.36B$8.2331.28

Summary

IQVIA beats Equifax on 9 of the 16 factors compared between the two stocks.

Get Equifax News Delivered to You Automatically

Sign up to receive the latest news and ratings for EFX and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding EFX and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

EFX vs. The Competition

MetricEquifaxProfessional Services IndustryIndustrials SectorNYSE Exchange
Market Cap$22.17B$8.33B$9.96B$23.07B
Dividend Yield1.18%3.73%2.94%3.82%
P/E Ratio29.1326.7430.8927.33
Price / Sales3.472.263.003.26
Price / Cash13.6021.9419.8415.54
Price / Book4.704.943.733.65
Net Income$660.30M$234.86M$612.29M$1.07B
7 Day Performance-4.12%-3.52%-3.34%-4.19%
1 Month Performance11.86%-0.63%-3.02%-2.47%
1 Year Performance-11.86%-2.29%1.94%5.85%

Equifax Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
EFX
Equifax
4.1842 of 5 stars
$180.33
-4.8%
$196.71
+9.1%
-12.0%$22.17B$6.07B29.1315,000
CRAI
Charles River Associates
4.2245 of 5 stars
$197.41
-0.1%
$245.00
+24.1%
+21.3%$1.24B$794.64M24.74959
APTV
Aptiv
4.6285 of 5 stars
$39.99
+1.4%
$69.02
+72.6%
-50.8%$8.10B$20.59B11.02140,000
BAH
Booz Allen Hamilton
4.1284 of 5 stars
$86.96
+1.9%
$89.29
+2.7%
+5.1%$10.31B$11.22B13.5031,500
G
Genpact
3.3356 of 5 stars
$42.63
+0.8%
$41.89
-1.7%
-2.4%$7.13B$5.08B12.43146,500

Related Companies and Tools


This page (NYSE:EFX) was last updated on 11/18/2026 by MarketBeat.com Staff.
From Our Partners